PTSD refers to the development of a cluster of characteristic symptoms that follow exposure to an extreme traumatic stressor and which appears to involve aberrant memory processing and impaired adaptation to changed environmental conditionsReference 1040. Characteristic symptoms include persistent, intrusive recollections, or a re-experiencing of the original traumatic event (through dreams, nightmares, and dissociative flashbacks), numbing and avoidance, and increased arousalReference 578. Patients with PTSD are also at risk for other psychological disorders, including but not limited to generalized anxiety disorder, major depressive disorder, and substance use disorder as well as physical problems including chronic pain, hypertension, and asthmaReference 1041. There appears to be a link between exposure to a traumatic event and cannabis use, especially in military veterans, and research suggests that individuals with PTSD may be particularly likely to use cannabis specifically to alleviate symptoms of PTSD and associated distressReference 1039Reference 1041Reference 1042. There is also evidence to suggest that particular symptoms and correlates of PTSD including anxiety, stress, insomnia and depression are among the most frequently cited reasons for cannabis useReference 1042.
I can honestly say that not sleeping (i used to sleep upright too) is a very dibilitating problem and you are doing the right thing by doing a sleep study. i would also check into other treatments as I have done if you find that apnea is not the culprit. According to my cardiologist, I have not had a heart attack as a result of my A-fib. After my first attack, I had all the tests, with the exception of the Holter.
The reported decrease in memory among a proportion of the study sample could be a function of cannabis use along with the use of other medications such as opioids, anti-depressants, or even vary with age. Limitations CBD gummies of the study included its observational nature, the lack of an appropriate control group, and the reliance on self-report. Nabiximols is the generic name for a whole-plant extract of two different, but standardized, strains of Cannabis sativa giving an oro-mucosal spray product containing approximately equivalent amounts of Δ9-THC (27 mg/mL) and CBD (25 mg/mL), and other cannabinoids, terpenoids, and flavonoids per 100 μl of dispensed spray.
Here, we present a case of inferior MI in a patient who had consumed cannabis regularly over a long period and whose coronary angiography revealed SCF. It is likely that there is an association between cannabis and ischemic stroke and transient ischemic attack (TIA). There are multiple reports of mainly younger men, with no vascular risk factors other than tobacco and alcohol use, with symptom onset during or soon after cannabis use.
In one experiment, treatment with 10 mg/kg of THC alone, a combination of 5 mg/kg THC and 10 mg/kg CBD, a combination of 10 mg/kg THC and 10 mg/kg CBD, or sulfasalazine alone was associated with a statistically significant decrease in the macroscopic damage score. Myeloperoxidase activity, a measure of granulocyte infiltration, was significantly decreased in CBD-treated rats and in rats treated with 10 or 20 mg/kg THC, or 5 mg/kg THC and 10 mg/kg CBD. Treatment with 10 mg/kg CBD, 10 mg/kg THC, 10 mg/kg THC and 10 mg/kg CBD, or sulfasalazine alone was also associated with decreased disturbances in colonic motility resulting from TNBS-induced colitis.